CNMD (CONMED Corporation) Stock Analysis - Community

CONMED Corporation (CNMD) is a publicly traded Healthcare sector company. As of May 21, 2026, CNMD trades at $36.68 with a market cap of $1.10B and a P/E ratio of 24.16. CNMD moved +1.96% today. Year to date, CNMD is -11.63%; over the trailing twelve months it is -38.15%. Its 52-week range spans $33.21 to $78.00. Analyst consensus is neutral with an average price target of $39.24. Rallies surfaces CNMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

How does the Rallies community trade CNMD?

Rallies community data for CNMD shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.

CNMD Key Metrics

Key financial metrics for CNMD
MetricValue
Price$36.68
Market Cap$1.10B
P/E Ratio24.16
EPS$1.52
Dividend Yield0.20%
52-Week High$78.00
52-Week Low$33.21
Volume70
Avg Volume0
Revenue (TTM)$1.37B
Net Income$47.05M
Gross Margin54.59%

Latest CNMD News

Recent CNMD Insider Trades

  • Glaze Richard sold 257 (~$10.59K) on Nov 21, 2025.
  • Garner Todd W sold 3.50K (~$150.50K) on Nov 6, 2025.
  • Farkas Charles sold 1.10K (~$59.05K) on Sep 12, 2025.

CNMD Analyst Consensus

4 analysts cover CNMD: 0 strong buy, 0 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $39.24.

Common questions about CNMD

How does the Rallies community trade CNMD?
Rallies community data for CNMD shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Does Rallies show retail investor data for CNMD?
Rallies shows anonymized community ownership, retail positioning, sentiment, and portfolio context for CNMD when enough community data is available.
Is CNMD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CNMD. It does not provide personalized investment advice.
CNMD

CNMD